Validity and Reliability of the Postural Habits and Awareness Scale

NCT ID: NCT07014670

Last Updated: 2025-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-25

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to examine the validity and reliability of the Turkish version of the Postural Habits and Awareness Scale in Fibromyalgia patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postural Habit and Awareness Scale is a scale developed for healthy individuals. For this reason, when applying to any disease group, other parameters belonging to that disease group should also be evaluated. For this purpose, Fibromyalgia Impact Questionnaire, Body Perception Scale, Body Awareness Questionnaire, Visual Analog Scale and Short Form-12 questionnaires were also used in the study. Fibromyalgia is a disease that affects the whole body and generally causes pain and stiffness complaints. For this reason, the whole body should be evaluated. Fibromyalgia Impact Questionnaire was used to define and indicate the level of fibromyalgia effects of the patients. For validity and reliability analyses, Body Perception Scale and Body Awareness Questionnaire questionnaires were used to compare the Postural Habit and Awareness scale. At the same time, Short Form-12 questionnaire was used to examine the patients' pain severity and the effects of the disease on daily life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Validation and Reability study

Validation and Reability study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who have been diagnosed with Fibromyalgia according to the American Rheumatology Association criteria and have been over for at least 6 months,
* Those who do not have a history of any psychiatric disease,
* Those who have the ability to lie down, sit and stand without any assistance.

Exclusion Criteria

* Pregnant individuals,
* Those who have pain complaints due to another disease (rheumatic, heart or infectious diseases),
* Those who make changes in physical activity and lifestyle during work,
* Those with any neurological disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bitlis Eren University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abdurrahman Tanhan

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bitlis Eren University

Bitlis, Merkez, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BitlisErenU3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.